Skip to main content
. 2017 Sep 28;8(65):109723–109731. doi: 10.18632/oncotarget.21299

Figure 1. Efficacy of sorafenib for overall survival Shows forest plot of hazard ratio of overall survival of patients with hepatocellular carcinoma after resection who treated with sorafenib versus control.

Figure 1

Data of 4 studies were pooled using fixed-effects model. Studies are sorted by publication year.